Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Laughing gas ban ‘will not stop young people using it’, say experts

The Drug Science Scientific Committee also said a blanket ban on nitrous oxide was ‘completely disproportionate’ to the harms it caused.

The Independent UK

3 Large-Cap Pharma Stocks to Protect Your Portfolio Through 2023

The worst banking crisis since 2008 could not stop the Fed from raising the benchmark interest rate. The possibility of further policy tightening and strict lending standards for banks might push the economy into a recession this year. Therefore, investing in large-cap pharma stocks Johnson & Johnson (JNJ), Merck &…

StockNews.com

A blinding bacteria, four dead and an everyday brand blamed: What we know about the US eye drop recall

People have had to have their eyes surgically removed due to the bacteria

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Biotech Stocks to Buy Hand Over Fist in March

The biotech industry is expected to expand rapidly, driven by significant advancements and government initiatives. Furthermore, this sector tends to be relatively defensive and holds up relatively well during downturns. So, fundamentally sound biotech stocks Gilead Sciences (GILD) and Vertex Pharmaceuticals (VRTX) might be ideal buys now. Keep reading.

StockNews.com

Law Restricting Pharmacist Speech About Ivermectin and Hydroxycholoroquine Likely Violates the First Amendment

A federal judge issued a preliminary injunction against the enforcement of the law.

Reason

LA Sheriff's Department saw signs of deadly street drug 4 years ago, told health officials about it this month

LOS ANGELES — It was at least four years ago that Los Angeles County Sheriff’s Department officials say they began finding signs of a dangerous sedative infiltrating the local drug supply.

Los Angeles Times

Senators press Moderna CEO on COVID-19 vaccine price hike

Moderna’s CEO is defending a plan to more than quadruple the company’s COVID-19 vaccine price

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Novartis scraps cholesterol drug trial in blow to UK life sciences ambitions

Swiss firm’s withdrawal from Leqvio trial with NHS dents government plans to attract post-Brexit research and investment

The Guardian - UK

LOCALIZE IT: States weigh stricter fentanyl penalties

EDITORS/NEWS DIRECTORS:

The Independent UK

The Best Medical Stock That Money Can Buy

The medical industry, which thrived during the pandemic years, is envisioned to remain buoyed despite the economic headwinds, thanks to the inelastic demand the sector faces. Against this backdrop, we think the strong fundamentals of Johnson and Johnson (JNJ) make it a wise portfolio addition. Read on….

StockNews.com

US issues warning about Mexican pharmacies selling tainted, counterfeit pills

The U.S. State Department issued a warning Friday for Americans to “exercise caution” when buying medications from drug stores in Mexico, posting the health alert a week after a letter from two lawmakers and an investigation by the Los Angeles Times.

Los Angeles Times

Newsom announces $50 million contract to make California’s own brand of insulin

LOS ANGELES — California Gov. Gavin Newsom announced a new $50-million contract with the nonprofit generic drugmaker Civica to produce insulin under the state’s own label during a news conference Saturday in Downey.

Los Angeles Times

Four people forced to have their eyeballs removed after using contaminated eye drops

The Centres for Disease Control and Prevention has identified a rare strain of Pseudomonas aeruginosa in 68 patients across 16 states in the US due to contaminated eyedrops

Daily Mirror

Amid U.S. pressure on fentanyl, Mexico raises drug lab raids data

Mexico's army has dramatically revised upward the number of drug lab raids it says it conducted under President Andres Manuel Lopez Obrador, according to government data and leaked military documents reviewed by Reuters.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

The Street

Pfizer Recalls Over 4 Million Products for Scary Reason

Pfizer says its working to create new packaging for Nurtec ODT to comply with the child-resistant packaging requirements.

Investors Business Daily

Medicare Negotiation Undercuts Biotech Stocks Regeneron, Halozyme

Confusion over new Centers for Medicare and Medicaid Services negotiating plans sent REGN and HALO stocks tumbling Thursday.

The Guardian - UK

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

Tribune News Service

Judge weighs FDA approval of abortion drug

WASHINGTON — A federal district judge heard oral arguments Wednesday in a controversial case that could decide the fate of the Food and Drug Administration’s approval of the abortion drug mifepristone — a decision that would have broad ramifications nationwide.

Get all your
news in one place.

100’s of premium titles.
One news app.

Chicago Tribune

Federal government to penalize AbbVie over the price of its blockbuster drug Humira

North Chicago-based drugmaker AbbVie must pay back Medicare for raising the price of its blockbuster drug Humira too quickly, the federal government said Wednesday.

The Guardian - UK

Jeremy Hunt aims to spur business investment with ‘full expensing’ tax break

Measure over next three years will allow firms to write off costs of IT equipment and machinery against tax on profits

ABC News

Governments are increasingly reliant on consulting firms. Critics says it's often to their detriment

Critics say governments are outsourcing their own knowledge and activities to consulting firms, yet these firms aren't held to the same standards as the public sector.

The Independent UK

‘Near-automatic sign off’ – Hunt pledges £10m to speed up access to new drugs

The Chancellor said that £10 million would be awarded to help streamline approvals for new medical products.

StockNews.com

The Smartest Stock to Buy for Under $50 Now

Pharma giant Pfizer (PFE) had a successful fiscal year 2022 with record-breaking revenue and earnings. Moreover, its recent acquisition should boost its portfolio and revenue. Given the market volatility, this fundamentally strong stock might be an ideal buy for under $50. Keep reading.

Investors Business Daily

Biotech Stocks And The SVB Collapse — Here's What We Know

The collapse of SVB will leave early-stage biotech companies in a funding dearth. But big-name biotech stocks will emerge largely untouched.

StockNews.com

1 Stock to Buy This Week and Hold for the Next 20 Years

Although the stock market remains highly volatile, investing for the long term can never be timed perfectly. I believe buying fundamentally strong biopharmaceutical major Bristol-Myers Squibb (BMY) now for the long term could be wise, given the solid prospects of its new drug launches. Read more….

1 … 41 42 43 44

People

Dipanjan BanchurSince

Andres Manuel Lopez Obrador

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Justice Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.